Galderma Group
SWX:GALD
CHF 189,70
+ CHF4,50 (2,43%)
End-of-day quote: 10/29/2026
189,70 CHF
+CHF4,50 (2,43%)
End-of-day quote: 10/29/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

Not enough history for a GROWTH analysis

The GROWTH Investing analysis requires at least five years of stock market history to provide a precise and well-founded valuation. Stocks with at least three years of history offer significantly lower risk, as potential fluctuations and trends can be better analyzed and evaluated over a longer period. Since this stock hasn't been listed on the stock market for three years, we lack the necessary data to perform our calculations. The analysis will be available as soon as the necessary data is available.

G
0%
3-year Growth Rate
R
2/2
3-year Risk Analysis
O
33,07%
Outlook 12/26
W
-2,50%
Margin of safety
T
9,72%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 3Y
55,03%
Revenue growth 3Y
4,57%
Price growth 3Y
0,00%
Market Cap
CHF43,19 B
Long-Term Debt
CHF2,05 B
Quarterly earnings
10/30/2026
Dividend
CHF0,36
Dividend Yield
0,19%
Industry
Website
ISIN Number

Galderma Group Price Chart (CHF)

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

CHF208,14
9.72%
9.72
Last Update: 10/29/2026
Analysts: 17

Highest Price Target CHF266,87

Average Price Target CHF208,14

Lowest Price Target CHF135,99

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Galderma Group
SWX:GALD
144,61% 144,38% 0,23% 0,00% 2/2 33,07% -2,50% 11,39% UP

Financials

Dividend

Profile

Competitors

News

×